SBRA Sabra Health Care REIT Forecast, Technical & Fundamental Analysis

SBRA's Stochastic Oscillator is sitting in oversold zone for 12 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for SBRA's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

Following a +0.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where SBRA advanced for three days, in 213 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

SBRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 166 of 266 cases where SBRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SBRA as a result. In 44 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 48%.

The Moving Average Convergence Divergence Histogram (MACD) for SBRA turned negative on September 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 20 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 43%.

SBRA moved below its 50-day moving average on September 14, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SBRA crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 44%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.841) is normal, around the industry mean (3.199). P/E Ratio (76.269) is within average values for comparable stocks, (44.369). Projected Growth (PEG Ratio) (0.280) is also within normal values, averaging (1.649). Dividend Yield (0.060) settles around the average of (0.053) among similar stocks. P/S Ratio (5.889) is also within normal values, averaging (6.013).

The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. SBRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.